Adderall Articles
Stock Commentary - Europe
6 December 2001
Blow for Shire as Barr predicts early approval for generic Adderall
29 November 2001
Stock Commentary - Europe
29 November 2001
Shire earnings jump 54% for third quarter
7 November 2001
Shire launches Adderall XR in USA
31 October 2001
Stock Commentary - Europe
18 October 2001
Datamonitor expresses views on Celebrex vs Vioxx; Novartis ADHD drug
24 September 2001
Novartis' Ritadex is "approvable" in USA
23 August 2001
Stock Commentary - Europe
9 August 2001
Shire nears FDA OK for Adderall XR
8 August 2001
US state acts on school use of psychiatric drugs
20 July 2001
Shire's once-daily ADHD drug effective
10 May 2001
Shire looks ahead to once-daily Adderall XR results
12 March 2001
Shire reports revenues up 29% in calendar 2000
14 February 2001
Anagrelide granted orphan status in EU
9 January 2001
Shire Pharmaceuticals and BioChem Pharma announce $4 billion merger
11 December 2000
Shire 3rd-qtr pretax profits leap 67%
2 November 2000
First data with Shire's once-daily Adderall
27 October 2000
Shire files with FDA for SLI 381
5 October 2000
Novartis rejects Ritalin charges in the USA
19 September 2000
Novartis rejects Ritalin charges in the USA
15 September 2000
Shire reveals once-daily version of Adderall
8 September 2000
Good growth at Shire, Reminyl gets FDA boost
3 August 2000
Shire and Cortex link up for ADHD
26 April 2000
Shire's pretax profits climb 40% in 1st qtr
26 April 2000
Merger with Roberts going smoothly at Shire as revenues rise 30%
29 February 2000
Shire profits leap, now looking at Europe
21 October 1999
Shire benefits from strong US growth
13 May 1999
Shire profits grow despite Arenol bomb
16 March 1999
Shire set to divest US manufacturing plant
18 January 1999
Shire Relatively Happy With 3rd Qtr
23 November 1998
Shire Restarts Adderall Supplies
28 October 1998
Shire Pharmaceuticals Arrange ADD Drug Ingredients Supply
3 September 1998
Progress For Shire On Restarting ADHD Supplies
1 September 1998
Explosion At Arenol To Hit Shire Profits In 4th Qtr
18 August 1998
Explosion Impacts Shire Products
6 August 1998
Shire To Merge With Richwood In $186m Takeover
6 August 1997
New Player Enters US Attention Deficit Market
4 March 1996
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Elan makes "transformational" acquisitions and a divestment
